M&A / Deals Syneron raises $150m for macrocyclics, and other financings PharmaphorumOur round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.M&A / DealsRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder. M&A / DealsRead full story Post navigation Previous: Shionogi secures $482m BARDA contract to tackle AMR crisisNext: FDA seeks permanent future for rare pediatric priority review vouchers Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
